"A stroke is like a tsunami. I cannot let another one take me under again."
1 in 5 stroke survivors will have another stroke within 5 years, despite antiplatelet therapy.
“When my stroke happened, I felt very left behind. I never want to feel like that again.”
1 in 5 stroke survivors will have another stroke within 5 years, despite antiplatelet therapy.
"I was petrified of a second stroke. And I´m yet to meet a survivor who isn´t."
1 in 5 stroke survivors will have another stroke within 5 years, despite antiplatelet therapy.
“Recurrence is the biggest fear. Am I going to have another stroke?”
1 in 5 stroke survivors will have another stroke within 5 years, despite antiplatelet therapy.
“The thought of having another stroke? Scary.”
1 in 5 stroke survivors will have another stroke within 5 years, despite antiplatelet therapy.
“Every time my neck stiffens, I’m terrified it could be another stroke.”
1 in 5 stroke survivors will have another stroke within 5 years, despite antiplatelet therapy.
Secondary stroke prevention deserves another look
Recurrent stroke statistics, while shocking, are likely familiar. But behind the numbers we know there are harsh, personal realities. We have collaborated with six actual stroke survivors to highlight their stories as a reminder that together, we need to continue to strive for better outcomes for patients.
Bayer is working towards tackling the high recurrence rates that leave your patients vulnerable to another stroke.
Stroke and TIA overview
Every 3 seconds someone, somewhere, suffers a stroke. But it’s not just about statistics – the impact of stroke extends far beyond the initial event.
Secondary stroke prevention guidelines
With 20–30% of all strokes being recurrent, stroke survivors are at high risk of a secondary event. As an HCP, what is your current prevention strategy?
Need for action
Challenges in secondary stroke prevention result in high rates of recurrence. How many of your patients are vulnerable to another stroke?
Stroke survivor stories
Some battles are unseen. Six brave stroke survivors, alongside their care partners, are collaborating with Bayer to make their hearts and lives visible.
Stroke epidemiology quiz
How do you compare with your peers? Test your knowledge of stroke epidemiology and pathophysiology in the stroke epidemiology quiz.
Stacie's story
She lost her identity – but came back stronger as “Stacie 2.0”. Discover how she turned her stroke into a story of resilience.
Unmet needs, unseen risks
Stroke is the second leading cause of death globally. For survivors, the impact on everyday life can be severe. Despite adherence to guideline recommendations for stroke prevention, a significant proportion of survivors experience another stroke.
The invisible made visible:
In collaboration with actual stroke survivors
Strokes impact every survivor differently. Some effects may be physical and visible on the outside. Others can be emotional, making them invisible to those around them. Bayer is collaborating with six stroke survivors to shine a light on their everyday struggles – on how they cope with what they have already been through, and their fear of it happening all over again.
- Referencesexpand_less
- 1Kolmos M, et al. J Stroke Cerebrovasc Dis. 2021;30(8):105935.
- 2Kleindorfer DO, et al. Stroke. 2021;52(7):e364–e467.
- 3Feigin VL, et al. Lancet Neurol. 2024;23(10):973–1003.
- 4Feigin VL, et al. Lancet Neurol. 2023;22:1160–1206.
- 5Dawson J, et al. Eur Stroke J. 2022;7:I–XLI.
- 6Feigin VL, et al. Lancet Neurol. 2021;20(10):795–820.